High incidence of pacing-induced cardiomyopathy in patients with cardiac sarcoidosis

Heart Rhythm 2026 Open access

Read full text
Authors: David Nelson, Fahad Bijad Salah Alharbi, Anahita Tavoosi, Pablo B. Nery, Robert S.B. Beanlands, David Birnie
DOI: 10.1016/j.hrthm.2026.03.1960
Cited by: 1
References: 3

Abstract

Sarcoidosis is a multisystem, inflammatory granulomatous disease of unknown etiology. Patients with clinically manifest cardiac sarcoidosis (CS) commonly present with advanced conduction system disease. Current guidelines advise permanent pacing for these patients, and it is further recommended that they receive implantable cardioverter defibrillators (ICDs) because of the risk of sudden cardiac death.(1) However, there are no recommendations on when to implant cardiac resynchronization therapy (CRT).

Fields of Study & Subjects

Sarcoidosis and Beryllium Toxicity Research Cardiac pacing and defibrillation studies Pericarditis and Cardiac Tamponade

Publication details

Journal / source
Heart Rhythm
Publisher
Elsevier BV
Volume
23
Issue
10
Pages
e2645-e2647
Publication date
1 April 2026
Language
EN